SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 1,072.88 |
Enterprise Value ($M) | 1,153.83 |
Book Value ($M) | 461.26 |
Book Value / Share | 0.36 |
Price / Book | 2.33 |
NCAV ($M) | -122.38 |
NCAV / Share | -0.10 |
Price / NCAV | -8.77 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.18 |
Return on Assets (ROA) | -0.15 |
Return on Equity (ROE) | -0.22 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.63 |
Current Ratio | 0.96 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 69.68 |
Assets | 653.32 |
Liabilities | 192.06 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
MDIN – MedGen, Inc. | MDRM – Modern Mobility Aids, Inc. |
MEHCQ – 23andMe Holding Co. | MITPF – Mithra Pharmaceuticals SA |
MIXX – Mix1 Life, Inc. |
Financial data and stock pages provided by
Fintel.io